EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

CDISC Enables Efficient Streamlining of Clinical Trial Safety Evaluation

Geoffrey Mann, Thomas J Pedersen, Rebecca Lyzinski, Anisa Scott, Andrew J Foglia, John Cromer, Meichen Dong, Nora Varga, Sam Gardner, Christopher J Kirchberg, Byron A Wingerd, Russell D Wolfinger und 1 weitere

Journal of the Society for Clinical Data Management · 2023

DOI: 10.47912/jscdm.169 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Society for Clinical Data Management, 2023. Verfasst von Geoffrey Mann und 12 weiteren Autor:innen. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The use of standardized data formats has increasingly facilitated both the submission of clinical trial data by pharmaceutical companies and its review by regulatory agencies. The Clinical Data Interchange Standards Consortium (CDISC) format has become the de facto worldwide standard for clinical trial data submissions and review. CDISC data are captured and organized in defined datasets, or domains, with predefined variable names and attributes. As a result, researchers and reviewers have a consistent, repeatable, and rapid way to load, review, and analyze data. The benefits provided by this standardization have culminated in the development of software that intuitively utilizes CDISC structures to quickly import and analyze the data as well as summarize the results for scientists and clinicians in a collection of readable and easy-to-understand reports. In this paper, we will show how CDISC datasets with their required domains and respective variables can be utilized by JMP® Clinical to create clinical trial analysis reports easily and quickly with interactive graphs and tables for use in FDA New Drug Applications and Clinical Reviews. These reports are also ready for inclusion in regulatory submissions such as regulatory documents and clinical study reports to improve reviewability, interpretability, and efficiency of regulatory submission and review.

Zitieren

APA

Mann, G., Pedersen, T. J., Lyzinski, R., Scott, A., Foglia, A. J., Cromer, J., Dong, M., Varga, N., Gardner, S., Kirchberg, C. J., Wingerd, B. A., Wolfinger, R. D., & Bao, W. (2023). CDISC Enables Efficient Streamlining of Clinical Trial Safety Evaluation. Journal of the Society for Clinical Data Management. https://doi.org/10.47912/jscdm.169

Vancouver

Mann G, Pedersen TJ, Lyzinski R, Scott A, Foglia AJ, Cromer J, et al. CDISC Enables Efficient Streamlining of Clinical Trial Safety Evaluation. Journal of the Society for Clinical Data Management. 2023. doi:10.47912/jscdm.169

BibTeX
@article{Mann2023,
  author = {Mann, Geoffrey and Pedersen, Thomas J and Lyzinski, Rebecca and Scott, Anisa and Foglia, Andrew J and Cromer, John and Dong, Meichen and Varga, Nora and Gardner, Sam and Kirchberg, Christopher J and Wingerd, Byron A and Wolfinger, Russell D and Bao, Wenjun},
  title = {CDISC Enables Efficient Streamlining of Clinical Trial Safety Evaluation},
  journal = {Journal of the Society for Clinical Data Management},
  year = {2023},
  doi = {10.47912/jscdm.169}
}
Kostenlos starten →